Form 8-K - Current report:
SEC Accession No. 0001558370-16-010326
Filing Date
2016-12-01
Accepted
2016-12-01 11:56:18
Documents
19
Period of Report
2016-12-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc_8kgistmedicalmeetingpr.htm 8-K 42512
2 EX-99.1 bpmc_ex991.htm EX-99.1 43436
3 GRAPHIC bpmcex991001.gif GRAPHIC 174085
4 GRAPHIC bpmcex991002.gif GRAPHIC 66291
5 GRAPHIC bpmcex991003.gif GRAPHIC 93712
6 GRAPHIC bpmcex991004.gif GRAPHIC 81828
7 GRAPHIC bpmcex991005.gif GRAPHIC 96301
8 GRAPHIC bpmcex991006.gif GRAPHIC 66582
9 GRAPHIC bpmcex991007.gif GRAPHIC 78559
10 GRAPHIC bpmcex991008.gif GRAPHIC 96207
11 GRAPHIC bpmcex991009.gif GRAPHIC 67184
12 GRAPHIC bpmcex991010.gif GRAPHIC 102657
13 GRAPHIC bpmcex991011.gif GRAPHIC 71562
14 GRAPHIC bpmcex991012.gif GRAPHIC 98319
15 GRAPHIC bpmcex991013.gif GRAPHIC 62997
16 GRAPHIC bpmcex991014.gif GRAPHIC 72138
17 GRAPHIC bpmcex991015.gif GRAPHIC 64202
18 GRAPHIC bpmcex991016.gif GRAPHIC 63651
19 GRAPHIC bpmcex991017.gif GRAPHIC 54916
  Complete submission text file 0001558370-16-010326.txt   2032738
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 162027480
SIC: 2834 Pharmaceutical Preparations